Prudential Financial
AEGR

Prudential Financial’s Aegerion Pharmaceuticals AEGR Stock Holding History

Prudential Financial’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-10,748
Closed -$225K – 2272
2014
Q4 		$225K Sell
10,748
-245,600
-96% -$6.19M ﹤0.01% 2093
2014
Q3 		$8.56M Buy
256,348
+202,604
+377% +$6.29M 0.02% 750
2014
Q2 		$1.73M Buy
53,744
+42,896
+395% +$1.6M ﹤0.01% 1593
2014
Q1 		$500K Sell
10,848
-100
-0.9% -$5.86K ﹤0.01% 1948
2013
Q4 		$777K Sell
10,948
-26,900
-71% -$2.06M ﹤0.01% 1837
2013
Q3 		$3.24M Buy
37,848
+27,590
+269% +$2.34M 0.01% 1144
2013
Q2 		$650K Buy
+10,258
New +$545K ﹤0.01% 1861

Other funds holding AEGR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Prudential Financial's AEGR Position: Q1 2015 in Review

Prudential Financial sold out of Aegerion Pharmaceuticals (AEGR) in Q1 2015, closing a stake of 10,748 shares — an estimated $225K sold.

Prudential Financial first reported a position in AEGR in Q2 2013 and held it in 7 quarters. The position peaked at $8.56M in Q3 2014. 99 funds tracked by Wall St. Rank hold AEGR as of Q1 2015.

  • Prudential Financial reported no remaining Aegerion Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Prudential Financial sold 10,748 Aegerion Pharmaceuticals shares in Q1 2015, an estimated $225K.
  • Prudential Financial first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 7 quarters.
  • Prudential Financial's Aegerion Pharmaceuticals position peaked at $8.56M in Q3 2014.
  • 99 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q1 2015.

Based on Prudential Financial's 13F filing for Q1 2015, filed 1 May 2015.